Business
Covalon Annual Shareholders Meeting To Be Held Thursday April 14th, 2011 at 9:00 am
Apr. 12, 2011 (Canada NewsWire Group) -- MISSISSAUGA, ON, April 12 /CNW/ - Covalon Technologi...
About this update from Covalon Technologies Ltd.
[{"type":"text","content":"\n\n\n Apr. 12, 2011 (Canada NewsWire Group) -- \n\n#ReleaseContent TABLE\n{\n BORDER-COLLAPSE: collapse\n}\nTR.cnwUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTR.cnwDoubleUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTR.cnwBoldUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px solid\n}\nTD.cnwUnderlinedCell\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTD.cnwDoubleUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTD.cnwBoldUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px solid\n}\n#ReleaseContent TABLE.cnwBorderedTable TD\n{\n BORDER-RIGHT: black 1px solid;\n PADDING-RIGHT: 2px;\n BORDER-TOP: black 1px solid;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n BORDER-LEFT: black 1px solid;\n PADDING-TOP: 2px;\n BORDER-BOTTOM: black 1px solid;\n BORDER-COLLAPSE: collapse\n}\n#ReleaseContent TABLE TD\n{\n PADDING-RIGHT: 2px;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n PADDING-TOP: 2px\n}\n\n\nMISSISSAUGA, ON, April 12 /CNW/ - Covalon Technologies Ltd. (the\n "Company" or "Covalon") (TSXV: COV), an advanced medical technologies\n company, today announced a reminder that its annual general and special\n meeting of shareholders will be held at 9:00 am on Thursday, April 14,\n 2011 at the offices of Stikeman Elliott LLP, 53rd Floor, Commerce Court\n West, 199 Bay Street, Toronto, Ontario. A previous press release\n included an incorrect time for the meeting.\n\n\nAbout Covalon\n\n\nCovalon Technologies Ltd. is a unique medical technologies company\n engaged in the research, development, and commercialization of advanced\n tissue repair applications, infection control, and specialized coatings\n for medical and consumer products. Together, our technology platforms,\n wound care products, and consulting services deliver a suite of\n cost-effective solutions to help our customers achieve product\n differentiation through improved patient outcomes. Our technologies\n address important healthcare issues such as infection control, medical\n device biocompatibility and healthy tissue repair. To learn more about\n Covalon, visit our website at www.covalon.com\n\n\nNeither TSX Venture Exchange nor its Regulation Services Provider (as\n that term is defined in the policies of the TSX Venture Exchange) accepts\n responsibility for the adequacy or accuracy of this release.\n\n\nThis news release con...